| Stephen Mark Delgiudice, MD | |
|
253 Pleasant St, Concord, NH 03301-7560 | |
| (603) 226-2200 | |
| Not Available |
| Full Name | Stephen Mark Delgiudice |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 253 Pleasant St, Concord, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336161652 | NPI | - | NPPES |
| 30002489 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 7518 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Stephen Mark Delgiudice, MD 253 Pleasant St, Concord, NH 03301-7560 Ph: (603) 226-2200 | Stephen Mark Delgiudice, MD 253 Pleasant St, Concord, NH 03301-7560 Ph: (603) 226-2200 |
News Archive
Online sexual hook-ups present a unique opportunity to explore many factors of decision-making that inform sexual health. A study conducted by Eric Schrimshaw, PhD, at Columbia University's Mailman School of Public Health and Martin J. Downing, Jr., PhD, of the National Development and Research Institutes, found evidence that men having sex with men use the Internet to find sexual partners who do not identify as gay, either to fulfill a fantasy or because it allows anonymous sexual encounters without discovery.
Researchers presented data today on ARQ 092, an AKT inhibitor in Phase 1 clinical development by ArQule, Inc. at the AACR Annual Meeting held in Washington, D.C., April 6-10, showing that this novel, oral agent inhibits the AKT pathway and has a manageable safety profile in an ongoing Phase 1 clinical trial.
The Irish Minister for Health and Children, Mr Micheál Martin, TD, and the Minister with responsibility for Health, Social Services and Public Safety, (Belfast) Ms Angela Smith, MP today, (30th April, 2004), announced the publication of a Feasibility Study on a Helicopter Emergency Medical Service (HEMS) for the island of Ireland.
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the United States Patent and Trademark Office (USPTO) has allowed an Isis patent application that further expands the scope of the "Crooke" patent estate. The newly allowed patent broadly covers methods of cleaving a target RNA via a double-stranded ribonuclease mechanism, including the RNAi mechanism, with chemically modified, single-stranded RNA-containing drugs.
Geron Corp. is removing itself from the field it pioneered – stem cell research. Late Monday, the company said it would halt its study of a stem cell-based treatment for spinal cord injury, the first embryonic stem cell trial approved in the U.S.
› Verified 6 days ago
Nava Chana Greenfield, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Concord, NH 03301 Phone: 603-226-6119 | |
Andrew Kim, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Dartmouth Hitchcock - Dermatology, Concord, NH 03301 Phone: 603-226-6119 | |
Dr. Peter Jonathan Sands, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 253 Pleasant St, Concord, NH 03301 Phone: 603-226-2200 | |
Dr. Paul Dacy Espy, MD Dermatology Medicare: Medicare Enrolled Practice Location: 253 Pleasant St, Dartmouth Hitchcock - Dermatology, Concord, NH 03301 Phone: 603-229-5200 | |
Scott Howard Deckelbaum, DO Dermatology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St Ste 2800, Concord, NH 03301 Phone: 603-415-6464 Fax: 603-227-7576 | |
Alexandra E Charos, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 248 Pleasant St Ste 2800, Concord, NH 03301 Phone: 603-415-6464 Fax: 603-227-7576 |